Send a Tweet
Most Popular Choices
Poll Analyses
Share on Facebook 24 Share on Twitter 4 Printer Friendly Page More Sharing
Best Web OpEds    H2'ed 5/22/19

Dow Chemical Donates $1 Million to Trump, Asks Administration to Ignore EPA Pesticide Study

Author 4578
Message Stephen Fox
Become a Fan
  (31 fans)

The fact that C.E.O. Andrew Liveris is a close adviser to Donald Trump can’t hurt. Chlorpyrifos, diazinon, and malathion are big Dow Chemical money-maker pesticides, with the company selling  5 million pounds of chlorpyrifos in the U.S. yearly, according to the AP. Dow has a small problem on its hands, and it’s not the fact that the pesticide was “originally derived from a nerve gas developed by Nazi Germany,” per the AP, though that’s certainly not great for marketing materials. It’s the fact that studies by federal scientists have found that chlorpyrifos, diazinon, and malathion are harmful to almost 1,800 “critically threatened or endangered species.” EPA will issue findings resulting in new limits on how and where the highly toxic pesticides can be used.

Read the rest of the story HERE:

At www.vanityfair.com

 

Must Read 1   Supported 1   Valuable 1  
Rate It | View Ratings

Stephen Fox Social Media Pages: Facebook page url on login Profile not filled in       Twitter page url on login Profile not filled in       Linkedin page url on login Profile not filled in       Instagram page url on login Profile not filled in


Early in the 2016 Primary campaign, I started a Facebook group: Bernie Sanders: Advice and Strategies to Help Him Win! As the primary season advanced, we shifted the focus to advancing Bernie's legislation in the Senate, particularly the (more...)
 

Go To Commenting
The views expressed herein are the sole responsibility of the author and do not necessarily reflect those of this website or its editors.
Writers Guidelines
Contact AuthorContact Author Contact EditorContact Editor Author PageView Authors' Articles
Support OpEdNews

OpEdNews depends upon can't survive without your help.

If you value this article and the work of OpEdNews, please either Donate or Purchase a premium membership.

STAY IN THE KNOW
If you've enjoyed this, sign up for our daily or weekly newsletter to get lots of great progressive content.
Daily Weekly     OpEdNews Newsletter
Name
Email
   (Opens new browser window)
 

To View Comments or Join the Conversation: